J

Active Director Director DIN 08664167
DIN 08664167 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Jeetender

Data last updated:

Jeetender is a Director at Kovish Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Kovish Pharmaceuticals Private Limited reported revenue of ₹36.5 Lakh (FY 2025).

DIN 08664167
Primary Designation Director
Industry Chemicals
First Appointment 09 Jan 2020
Oldest Company Age 6 yrs
Largest company Kovish Pharmaceuticals Private Limited · ₹36.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jan 20202020₹36.5 Lakh (FY 2025)Active

Board colleagues of Jeetender

NameDINCompanyDesignation
Meenu08664168Kovish Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kovish Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jeetender

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeetender

Jeetender currently holds 1 directorship: Kovish Pharmaceuticals Private Limited (Director, since 09 Jan 2020, revenue ₹36.5 Lakh (FY 2025)).

Jeetender was first appointed on 09 Jan 2020 as Director at Kovish Pharmaceuticals Private Limited.

The current boards of Jeetender's companies include Meenu (Kovish Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available